This research employs first-principles simulations to systematically study the structural, elastic, electronic mechanical, and optical characteristics of lead free halide RbAgBiX (X = Br, Cl) perovskites under pressure. The computed structural parameters are in good agreement with previous experimental and theoretical results. The obtained elastic constants met the Born stability requirements, showing that our materials are mechanically stable at variable hydrostatic pressures, as supported by the computed negative formation energy values. The covalent bond exhibits metallic characteristics, and induced hydrostatic pressure leads to a decrease in bond lengths. Mechanical analysis demonstrates that the studied materials are ductile and mechanically stable, with enhanced ductility under pressure. The materials are small band gap (1.30 eV, 1.801 eV for RbAgBiX (X = Br, Cl, respectively) semiconductors at ambient pressure with superior optoelectronic performance. Under hydrostatic pressure, RbAgBiX (X = Br, Cl) experiences a reduction in its band gap (0.545 eV, 1.305 eV for RbAgBiX (X = Br, Cl, respectively), accompanied by improved physical characteristics. This suggests the potential for increased utilization of this material in optoelectronic devices and solar cells compared to ambient pressure conditions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11536014 | PMC |
http://dx.doi.org/10.1016/j.heliyon.2024.e39285 | DOI Listing |
Circ Genom Precis Med
October 2023
Institute of Cardiovascular Science, University College London, United Kingdom (D.E.C., A.P., A.B., P.S., M.L., P.M.E.).
Background: Variants in are reported in 2% to 6% of familial cases of dilated cardiomyopathy and may be associated with fatal ventricular arrhythmia and rapid heart failure progression. We sought to determine the risk of adverse events in variant carriers and the impact of sex on outcomes.
Methods: Consecutive probands and relatives carrying variants were retrospectively recruited from 12 cardiomyopathy units.
Int J Biol Macromol
February 2018
Biochemistry Department/Laboratory of Immunopathology Keizo Asami (LIKA), Universidade Federal de Pernambuco-UFPE, Av. Prof. Moraes Rego s/n, CEP 50.670-420, Recife, PE, Brazil. Electronic address:
This study evaluated the l-ascorbic acid (AA) encapsulation in microparticles of xyloglucan (XAA) extracted from Hymenaea courbaril seeds by spray drying (SD) and its application in tilapia fish burgers. The encapsulation efficiency was 96.34±1.
View Article and Find Full Text PDFRegul Pept
December 2011
Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, Santo André, SP 09210-170, Brazil.
Angiotensin II (AII) is the active octapeptide product of the renin enzymatic cascade, which is responsible for sustaining blood pressure. In an attempt to establish the AII-receptor-bound conformation of this octapeptide, we designed conformationally constrained analogues by scanning the entire AII sequence with an i-(i+2) and i-(i+3) lactam bridge consisting of an Asp-(Xaa)(n)-Lys scaffold. Most analogues presented low agonistic activity when compared to AII in the different bioassays tested.
View Article and Find Full Text PDFClin Chim Acta
October 2000
Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Lineu Prestes 580, CEP 05508-900, SP, São Paulo, Brazil.
The possible association of genetic markers at the apolipoprotein E (HhaI polymorphism), apolipoprotein B (XbaI, EcoRI and Ins/Del polymorphisms), and low-density lipoprotein receptor (LDLR) (AvaII, HincII and PvuII polymorphisms) with coronary artery disease (CAD) was evaluated in 50 Brazilian women with CAD diagnosed by angiography and in 100 healthy women (controls). The frequency of E3/E4 genotype for HhaI polymorphism at the Apo E gene was significantly higher in CAD patients than in controls (40% vs. 14%, respectively, P<0.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!